Xanthine oxidoreductase mediates genotoxic drug‐induced autophagy and apoptosis resistance by uric acid accumulation and <scp>TGF</scp> ‐β‐activated kinase 1 ( <scp>TAK</scp> 1) activation-Reference-Cited by-同舟云学术

Xanthine oxidoreductase mediates genotoxic drug‐induced autophagy and apoptosis resistance by uric acid accumulation and TGF ‐β‐activated kinase 1 ( TAK 1) activation

Published:2022-12-30 Issue:2 Volume:37 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Wang Jingxiang¹,Hu Yanhua¹,Liu Penggang¹,Xu Xiulong¹²^ORCID

Affiliation:

1. Institute of Comparative Medicine, College of Veterinary Medicine Yangzhou University Yangzhou China

2. Jiangsu Co‐innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis Yangzhou University Yangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202201436R

Reference53 articles.

1. Xanthine oxidoreductase in cancer: more than a differentiation marker

2. Xanthine oxidoreductase: One enzyme for multiple physiological tasks

3. The double faced role of xanthine oxidoreductase in cancer

4. Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses

5. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonlinear relationship between oxidative balance score and hyperuricemia: analyses of NHANES 2007–2018;Nutrition Journal;2024-05-04

2. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence;Cancer Letters;2023-08